{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:05:33Z","timestamp":1782493533628,"version":"3.54.5"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10022-4","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:59:19Z","timestamp":1778853559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Aging promotes a RAGE-dependent increase in breast cancer metastasis"],"prefix":"10.1038","volume":"9","author":[{"given":"Philip","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Magna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxiang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Benitez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2151-4807","authenticated-orcid":false,"given":"Thomas","family":"Heist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8398-5997","authenticated-orcid":false,"given":"Nanette H.","family":"Bishopric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne S.","family":"Mandelblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Panov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce M.","family":"Slingerland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7647-8121","authenticated-orcid":false,"given":"Barry I.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"10022_CR1","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.amepre.2013.10.029","volume":"46","author":"MC White","year":"2014","unstructured":"White, M. C. et al. Age and cancer risk: a potentially modifiable relationship. Am. J. Prev. Med. 46, S7\u2013S15 (2014).","journal-title":"Am. J. Prev. Med."},{"key":"10022_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"10022_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.breast.2023.06.001","volume":"70","author":"EB Jackson","year":"2023","unstructured":"Jackson, E. B. et al. Does age affect outcome with breast cancer? Breast 70, 25\u201331 (2023).","journal-title":"Breast"},{"key":"10022_CR4","doi-asserted-by":"publisher","first-page":"e2236149","DOI":"10.1001\/jamanetworkopen.2022.36149","volume":"5","author":"SWJ Lau","year":"2022","unstructured":"Lau, S. W. J. et al. Participation of older adults in clinical trials for new drug applications and biologics license applications from 2010 through 2019. JAMA Netw. Open 5, e2236149 (2022).","journal-title":"JAMA Netw. Open"},{"key":"10022_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.semradonc.2021.11.003","volume":"32","author":"IM Bumanlag","year":"2022","unstructured":"Bumanlag, I. M., Jaoude, J. A., Rooney, M. K., Taniguchi, C. M. & Ludmir, E. B. Exclusion of older adults from cancer clinical trials: review of the literature and future recommendations. Semin. Radiat. Oncol. 32, 125\u2013134 (2022).","journal-title":"Semin. Radiat. Oncol."},{"key":"10022_CR6","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.1158\/1078-0432.CCR-21-1549","volume":"27","author":"AML Wu","year":"2021","unstructured":"Wu, A. M. L. et al. Aging and CNS myeloid cell depletion attenuate breast cancer brain metastasis. Clin. Cancer Res. 27, 4422\u20134434 (2021).","journal-title":"Clin. Cancer Res."},{"key":"10022_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1265304","volume":"13","author":"Y Xie","year":"2023","unstructured":"Xie, Y. et al. Age has a U-shaped relationship with breast cancer outcomes in women: a cohort study. Front. Oncol. 13, 1265304 (2023).","journal-title":"Front. Oncol."},{"key":"10022_CR8","first-page":"590","volume":"307","author":"W van de Water","year":"2012","unstructured":"van de Water, W. et al. Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA 307, 590\u2013597 (2012).","journal-title":"JAMA"},{"key":"10022_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1634\/theoncologist.2012-0315","volume":"18","author":"W van de Water","year":"2013","unstructured":"van de Water, W. et al. Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysis. Oncologist 18, 8\u201313 (2013).","journal-title":"Oncologist"},{"key":"10022_CR10","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1002\/cncr.31308","volume":"124","author":"RA Freedman","year":"2018","unstructured":"Freedman, R. A. et al. Breast cancer-specific survival by age: worse outcomes for the oldest patients. Cancer 124, 2184\u20132191 (2018).","journal-title":"Cancer"},{"key":"10022_CR11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10549-020-05727-x","volume":"182","author":"AK Tzikas","year":"2020","unstructured":"Tzikas, A. K., Nemes, S. & Linderholm, B. K. A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns. Breast Cancer Res. Treat. 182, 643\u2013654 (2020).","journal-title":"Breast Cancer Res. Treat."},{"key":"10022_CR12","doi-asserted-by":"publisher","first-page":"117242","DOI":"10.1016\/j.lfs.2019.117242","volume":"242","author":"S Wang","year":"2020","unstructured":"Wang, S., Lai, X., Deng, Y. & Song, Y. Correlation between mouse age and human age in anti-tumor research: significance and method establishment. Life Sci. 242, 117242 (2020).","journal-title":"Life Sci."},{"key":"10022_CR13","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1177\/153537020422900711","volume":"229","author":"C Gravekamp","year":"2004","unstructured":"Gravekamp, C. et al. Behavior of metastatic and nonmetastatic breast tumors in old mice. Exp. Biol. Med. 229, 665\u2013675 (2004).","journal-title":"Exp. Biol. Med."},{"key":"10022_CR14","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s43018-023-00525-y","volume":"4","author":"FK Turrell","year":"2023","unstructured":"Turrell, F. K. et al. Age-associated microenvironmental changes highlight the role of PDGF-C in ER(+) breast cancer metastatic relapse. Nat. Cancer 4, 468\u2013484 (2023).","journal-title":"Nat. Cancer"},{"key":"10022_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13665","volume":"21","author":"EC Jenkins","year":"2022","unstructured":"Jenkins, E. C. et al. Age alters the oncogenic trajectory toward luminal mammary tumors that activate unfolded proteins responses. Aging Cell 21, e13665 (2022).","journal-title":"Aging Cell"},{"key":"10022_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","volume":"908","author":"C Franceschi","year":"2000","unstructured":"Franceschi, C. et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908, 244\u2013254 (2000).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10022_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","volume":"20","author":"M Fane","year":"2020","unstructured":"Fane, M. & Weeraratna, A. T. How the ageing microenvironment influences tumour progression. Nat. Rev. Cancer 20, 89\u2013106 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"10022_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nri2471","volume":"9","author":"K Dorshkind","year":"2009","unstructured":"Dorshkind, K., Montecino-Rodriguez, E. & Signer, R. A. The ageing immune system: is it ever too old to become young again? Nat. Rev. Immunol. 9, 57\u201362 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"10022_CR19","doi-asserted-by":"publisher","first-page":"104297","DOI":"10.1016\/j.cellimm.2021.104297","volume":"362","author":"G Pawelec","year":"2021","unstructured":"Pawelec, G., Picard, E., Bueno, V., Verschoor, C. P. & Ostrand-Rosenberg, S. MDSCs, ageing and inflammageing. Cell. Immunol. 362, 104297 (2021).","journal-title":"Cell. Immunol."},{"key":"10022_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100128","volume":"8","author":"G Bahcecioglu","year":"2021","unstructured":"Bahcecioglu, G. et al. Aged breast extracellular matrix drives mammary epithelial cells to an invasive and cancer-like phenotype. Adv. Sci. 8, e2100128 (2021).","journal-title":"Adv. Sci."},{"key":"10022_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60250-9","volume":"10","author":"S Bansode","year":"2020","unstructured":"Bansode, S. et al. Glycation changes molecular organization and charge distribution in type I collagen fibrils. Sci. Rep. 10, 3397 (2020).","journal-title":"Sci. Rep."},{"key":"10022_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev.med.46.1.223","volume":"46","author":"M Brownlee","year":"1995","unstructured":"Brownlee, M. Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 46, 223\u2013234 (1995).","journal-title":"Annu. Rev. Med."},{"key":"10022_CR23","doi-asserted-by":"crossref","unstructured":"Harper, E. I. et al. Advanced glycation end products as a potential target for restructuring the ovarian cancer microenvironment: a pilot study. Int. J. Mol. Sci. 24, 9804 (2023).","DOI":"10.3390\/ijms24129804"},{"key":"10022_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1146\/annurev-med-041316-085215","volume":"69","author":"BI Hudson","year":"2018","unstructured":"Hudson, B. I. & Lippman, M. E. Targeting RAGE signaling in inflammatory disease. Annu. Rev. Med. 69, 349\u2013364 (2018).","journal-title":"Annu. Rev. Med."},{"key":"10022_CR25","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/carcin\/bgy012","volume":"39","author":"A Rojas","year":"2018","unstructured":"Rojas, A., Anazco, C., Gonzalez, I. & Araya, P. Extracellular matrix glycation and receptor for advanced glycation end-products activation: a missing piece in the puzzle of the association between diabetes and cancer. Carcinogenesis 39, 515\u2013521 (2018).","journal-title":"Carcinogenesis"},{"key":"10022_CR26","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.bbamcr.2008.11.016","volume":"1793","author":"E Leclerc","year":"2009","unstructured":"Leclerc, E., Fritz, G., Vetter, S. W. & Heizmann, C. W. Binding of S100 proteins to RAGE: an update. Biochim. Biophys. Acta 1793, 993\u20131007 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"10022_CR27","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.18632\/oncotarget.1908","volume":"5","author":"M Dahlmann","year":"2014","unstructured":"Dahlmann, M. et al. RAGE mediates S100A4-induced cell motility via MAPK\/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis. Oncotarget 5, 3220\u20133233 (2014).","journal-title":"Oncotarget"},{"key":"10022_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1158\/1541-7786.MCR-10-0394","volume":"9","author":"M Ichikawa","year":"2011","unstructured":"Ichikawa, M., Williams, R., Wang, L., Vogl, T. & Srikrishna, G. S100A8\/A9 activate key genes and pathways in colon tumor progression. Mol. Cancer Res. 9, 133\u2013148 (2011).","journal-title":"Mol. Cancer Res."},{"key":"10022_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep01215","volume":"3","author":"WR Swindell","year":"2013","unstructured":"Swindell, W. R. et al. Robust shifts in S100a9 expression with aging: a novel mechanism for chronic inflammation. Sci. Rep. 3, 1215 (2013).","journal-title":"Sci. Rep."},{"key":"10022_CR30","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/35012626","volume":"405","author":"A Taguchi","year":"2000","unstructured":"Taguchi, A. et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405, 354\u2013360 (2000).","journal-title":"Nature"},{"key":"10022_CR31","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/onc.2016.324","volume":"36","author":"T Kwak","year":"2017","unstructured":"Kwak, T. et al. Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis. Oncogene 36, 1559\u20131572 (2017).","journal-title":"Oncogene"},{"key":"10022_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-023-00564-9","volume":"9","author":"M Magna","year":"2023","unstructured":"Magna, M. et al. RAGE inhibitor TTP488 (azeliragon) suppresses metastasis in triple-negative breast cancer. NPJ Breast Cancer 9, 59 (2023).","journal-title":"NPJ Breast Cancer"},{"key":"10022_CR33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10549-013-2737-1","volume":"142","author":"C Yin","year":"2013","unstructured":"Yin, C. et al. RAGE-binding S100A8\/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition. Breast Cancer Res. Treat. 142, 297\u2013309 (2013).","journal-title":"Breast Cancer Res. Treat."},{"key":"10022_CR34","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.4049\/jimmunol.1201151","volume":"190","author":"PJ Vernon","year":"2013","unstructured":"Vernon, P. J. et al. The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells. J. Immunol. 190, 1372\u20131379 (2013).","journal-title":"J. Immunol."},{"key":"10022_CR35","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1158\/0008-5472.CAN-14-2161","volume":"75","author":"MW Nasser","year":"2015","unstructured":"Nasser, M. W. et al. RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment. Cancer Res. 75, 974\u2013985 (2015).","journal-title":"Cancer Res."},{"key":"10022_CR36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.canlet.2013.12.018","volume":"346","author":"T Biswas","year":"2014","unstructured":"Biswas, T., Gu, X., Yang, J., Ellies, L. G. & Sun, L. Z. Attenuation of TGF-beta signaling supports tumor progression of a mesenchymal-like mammary tumor cell line in a syngeneic murine model. Cancer Lett. 346, 129\u2013138 (2014).","journal-title":"Cancer Lett."},{"key":"10022_CR37","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.4049\/jimmunol.179.5.2851","volume":"179","author":"TJ Stewart","year":"2007","unstructured":"Stewart, T. J. & Abrams, S. I. Altered immune function during long-term host-tumor interactions can be modulated to retard autochthonous neoplastic growth. J. Immunol. 179, 2851\u20132859 (2007).","journal-title":"J. Immunol."},{"key":"10022_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01418-1","volume":"20","author":"A Le Naour","year":"2020","unstructured":"Le Naour, A. et al. EO771, the first luminal B mammary cancer cell line from C57BL\/6 mice. Cancer Cell Int. 20, 328 (2020).","journal-title":"Cancer Cell Int."},{"key":"10022_CR39","first-page":"237","volume":"8","author":"CN Johnstone","year":"2015","unstructured":"Johnstone, C. N. et al. Functional and molecular characterisation of EO771.LMB tumours, a new C57BL\/6-mouse-derived model of spontaneously metastatic mammary cancer. Dis. Model Mech. 8, 237\u2013251 (2015).","journal-title":"Dis. Model Mech."},{"key":"10022_CR40","first-page":"19 12 11","volume":"19","author":"M Elkin","year":"2001","unstructured":"Elkin, M. & Vlodavsky, I. Tail vein assay of cancer metastasis. Curr. Protoc. Cell Biol. 19, 19 12 11\u201319 12 17 (2001).","journal-title":"Curr. Protoc. Cell Biol."},{"key":"10022_CR41","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/carcin\/bgr101","volume":"32","author":"M Tafani","year":"2011","unstructured":"Tafani, M. et al. Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1\/2 and Akt and nuclear translocation of NF-kappaB. Carcinogenesis 32, 1167\u20131175 (2011).","journal-title":"Carcinogenesis"},{"key":"10022_CR42","first-page":"1399","volume":"52","author":"CJ Aslakson","year":"1992","unstructured":"Aslakson, C. J. & Miller, F. R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 52, 1399\u20131405 (1992).","journal-title":"Cancer Res."},{"key":"10022_CR43","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1002\/art.33493","volume":"64","author":"AA Bengtsson","year":"2012","unstructured":"Bengtsson, A. A. et al. Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in patients with systemic lupus erythematosus. Arthritis Rheum. 64, 1579\u20131588 (2012).","journal-title":"Arthritis Rheum."},{"key":"10022_CR44","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1165\/rcmb.2019-0297OC","volume":"62","author":"J Yang","year":"2020","unstructured":"Yang, J. et al. Diverse injury pathways induce alveolar epithelial cell CCL2\/12, which promotes lung fibrosis. Am. J. Respir. Cell Mol. Biol. 62, 622\u2013632 (2020).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10022_CR45","doi-asserted-by":"publisher","first-page":"28697","DOI":"10.18632\/oncotarget.7376","volume":"7","author":"SY Lim","year":"2016","unstructured":"Lim, S. Y., Yuzhalin, A. E., Gordon-Weeks, A. N. & Muschel, R. J. Targeting the CCL2-CCR2 signaling axis in cancer metastasis. Oncotarget 7, 28697\u201328710 (2016).","journal-title":"Oncotarget"},{"key":"10022_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10549-014-3122-4","volume":"148","author":"K Drews-Elger","year":"2014","unstructured":"Drews-Elger, K. et al. Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome. Breast Cancer Res. Treat. 148, 41\u201359 (2014).","journal-title":"Breast Cancer Res. Treat."},{"key":"10022_CR47","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10549-017-4366-6","volume":"166","author":"P Miller","year":"2017","unstructured":"Miller, P. et al. Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome. Breast Cancer Res. Treat. 166, 85\u201394 (2017).","journal-title":"Breast Cancer Res. Treat."},{"key":"10022_CR48","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu, S. Z. et al. A single-cell and spatially resolved atlas of human breast cancers. Nat. Genet. 53, 1334\u20131347 (2021).","journal-title":"Nat. Genet."},{"key":"10022_CR49","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1371\/journal.pbio.0060184","volume":"6","author":"AR Pico","year":"2008","unstructured":"Pico, A. R. et al. WikiPathways: pathway editing for the people. PLoS Biol. 6, e184 (2008).","journal-title":"PLoS Biol."},{"key":"10022_CR50","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1158\/2159-8290.CD-18-0193","volume":"9","author":"A Kaur","year":"2019","unstructured":"Kaur, A. et al. Remodeling of the collagen matrix in aging skin promotes melanoma metastasis and affects immune cell motility. Cancer Discov. 9, 64\u201381 (2019).","journal-title":"Cancer Discov."},{"key":"10022_CR51","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.18632\/oncotarget.1426","volume":"4","author":"PJ Sarvaiya","year":"2013","unstructured":"Sarvaiya, P. J., Guo, D., Ulasov, I., Gabikian, P. & Lesniak, M. S. Chemokines in tumor progression and metastasis. Oncotarget 4, 2171\u20132185 (2013).","journal-title":"Oncotarget"},{"key":"10022_CR52","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s42003-020-01246-z","volume":"3","author":"V Krishnan","year":"2020","unstructured":"Krishnan, V. et al. Omental macrophages secrete chemokine ligands that promote ovarian cancer colonization of the omentum via CCR1. Commun. Biol. 3, 524 (2020).","journal-title":"Commun. Biol."},{"key":"10022_CR53","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000330095","volume":"4","author":"G Srikrishna","year":"2012","unstructured":"Srikrishna, G. S100A8 and S100A9: new insights into their roles in malignancy. J. Innate Immun. 4, 31\u201340 (2012).","journal-title":"J. Innate Immun."},{"key":"10022_CR54","doi-asserted-by":"publisher","first-page":"100751","DOI":"10.1016\/j.esmoop.2022.100751","volume":"8","author":"M Valiente","year":"2023","unstructured":"Valiente, M., Sepulveda, J. M. & Perez, A. Emerging targets for cancer treatment: S100A9\/RAGE. ESMO Open 8, 100751 (2023).","journal-title":"ESMO Open"},{"key":"10022_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-14-12","volume":"14","author":"AH Burstein","year":"2014","unstructured":"Burstein, A. H. et al. Effect of TTP488 in patients with mild to moderate Alzheimer\u2019s disease. BMC Neurol. 14, 12 (2014).","journal-title":"BMC Neurol."},{"key":"10022_CR56","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cger.2019.03.001","volume":"35","author":"EM Groarke","year":"2019","unstructured":"Groarke, E. M. & Young, N. S. Aging and hematopoiesis. Clin. Geriatr. Med. 35, 285\u2013293 (2019).","journal-title":"Clin. Geriatr. Med."},{"key":"10022_CR57","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.2337\/db06-0221","volume":"55","author":"KM Myint","year":"2006","unstructured":"Myint, K. M. et al. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin. Diabetes 55, 2510\u20132522 (2006).","journal-title":"Diabetes"},{"key":"10022_CR58","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"10022_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 12, 323 (2011).","journal-title":"BMC Bioinform."},{"key":"10022_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"10022_CR61","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"10022_CR62","unstructured":"The Gene Ontology Consortium et al. The Gene Ontology Knowledgebase in 2023. Genetics 224, iyad031 (2023)."},{"key":"10022_CR63","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"10022_CR64","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) Hallmark Gene Set Collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"10022_CR65","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"M Milacic","year":"2024","unstructured":"Milacic, M. et al. The Reactome Pathway Knowledgebase 2024. Nucleic Acids Res. 52, D672\u2013D678 (2024).","journal-title":"Nucleic Acids Res."},{"key":"10022_CR66","doi-asserted-by":"publisher","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang, D. et al. SRplot: a free online platform for data visualization and graphing. PLoS ONE 18, e0294236 (2023).","journal-title":"PLoS ONE"},{"key":"10022_CR67","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638\u2013D646 (2023).","journal-title":"Nucleic Acids Res."},{"key":"10022_CR68","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 173, 400\u2013416 (2018).","journal-title":"Cell"},{"key":"10022_CR69","unstructured":"DuMouchel, W. H. & O\u2019Brien, F. L. Integrating a robust option into a multiple regression computing environment. In Computer Science and Statistics:Proc. 21st Symposium on the Interface (American Statistical Association, 1989)."},{"key":"10022_CR70","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/03610927708827533","volume":"6","author":"PW Holland","year":"1977","unstructured":"Holland, P. W. & Welsch, R. E. Robust regression using iteratively reweighted least-squares. Commun. Stat. Theory Methods 6, 813\u2013827 (1977).","journal-title":"Commun. Stat. Theory Methods"},{"key":"10022_CR71","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/00031305.1988.10475548","volume":"42","author":"JO Street","year":"1988","unstructured":"Street, J. O., Carroll, R. J. & Ruppert, D. Note on computing robust regression estimates via iteratively reweighted least squares. Am. Stat. 42, 152\u2013154 (1988).","journal-title":"Am. Stat."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10022-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10022-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10022-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:04:42Z","timestamp":1778857482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10022-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10022"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10022-4","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"28 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.I.H., J.S.M. are co-inventors on pending patent applications related to RAGE-targeted therapies, including applications for the treatment of breast cancer (B.I.H) and cancer-related cognitive decline (B.I.H., J.S.M.). They hold no equity and have received no personal income related to these intellectual property rights. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"661"}}